Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149825 · ClinicalTrials.gov registry record · Phase 2
Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00149825: Completed Phase 2 study, sponsored by Stanford University.
NCT00149825 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00149825, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression.
Interventions
- DRUG Escitalopram
- BEHAVIORAL CBTI
- BEHAVIORAL CTRL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00149825
The ClinicalTrials.gov registry entry for NCT00149825 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Escitalopram is the first listed.
NCT00149825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00149825 about?
NCT00149825 is a clinical study titled "Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome". This study will examine the effectiveness of a combination of antidepressant medication and sleep-focused psychotherapy to simultaneously treat sleep difficulties and depression.
What is the current status of trial NCT00149825?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2004-06. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00149825?
The interventions under investigation include: Escitalopram (DRUG), CBTI (BEHAVIORAL), CTRL (BEHAVIORAL).
Who is sponsoring clinical trial NCT00149825?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.